The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium.  Arbli, an angiotensin II receptor ...

The new strut was filled with a pressurized compressible liquid capable of supporting vehicle load and damping in a single element. Today, LiquidSpring continues to develop suspension products for ...

The investment of over $6 million will expand LGM Pharma’s Rosenberg, Texas manufacturing facility as part of its Phase I ...

LGM Pharma invests $6 mn in US drug manufacturing facility to increase capacity for liquid, suspension, semi-solid & suppository drug products: Boca Raton, Florida Saturday, March ...